Alpha-type phospholipase A₂ inhibitors from snake blood

Area of Science:

• Biochemistry
• Toxicology
• Immunology

Background:

• Snake venom contains toxins like phospholipase A2 (PLA2) and myotoxins.
• Both venomous and non-venomous snakes possess PLA2 inhibitory proteins (PLIs) in their blood serum.
• The presence of PLIs in non-venomous snakes suggests roles beyond self-protection, potentially in innate immunity.

Purpose of the Study:

• To review existing literature on PLA2 and myotoxin alpha inhibitors in snake plasma.
• To elucidate the mechanisms of action of these snake plasma inhibitors.
• To propose these molecules as novel therapeutic agents for snakebite treatment.

Main Methods:

• Literature review of scientific articles on snake plasma inhibitors.
• Analysis of the proposed physiological roles and mechanisms of action of PLIs.
• Evaluation of the potential of PLIs in complementary snakebite therapy.

Main Results:

• PLIs are found in the serum of both venomous and non-venomous snakes.
• PLIs may offer self-protection against endogenous PLA2 enzymes and toxins.
• PLIs could be involved in innate immunity and local regulation of PLA2 activity.

Conclusions:

• Snake plasma inhibitors (PLIs) are crucial molecules with potential therapeutic applications.
• Understanding PLI mechanisms can lead to new snakebite treatments.
• PLIs offer a promising avenue for neutralizing diverse snake venom phospholipases A2 and myotoxins.